Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Document And Entity Information

v3.26.1
Document And Entity Information
 12 Months Ended
Dec. 31, 2025
shares
Document Information [Line Items]  
Document Type 20-F
Document Registration Statement false
Document Annual Report true
Document Transition Report false
Document Shell Company Report false
Document Accounting Standard U.S. GAAP
Document Financial Statement Error Correction [Flag] false
Entity Interactive Data Current Yes
ICFR Auditor Attestation Flag false
Amendment Flag false
Document Period End Date Dec. 31, 2025
Document Fiscal Year Focus 2025
Document Fiscal Period Focus FY
Entity Registrant Name Can-Fite BioPharma Ltd.
Entity Central Index Key 0001536196
Entity File Number 001-36203
Entity Incorporation, State or Country Code L3
Current Fiscal Year End Date --12-31
Entity Well-known Seasoned Issuer No
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Shell Company false
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company false
Entity Address, Address Line One 26 Ben Gurion Street
Entity Address, City or Town Ramat Gan
Entity Address, Postal Zip Code 5257346
Entity Address, Country IL
Title of 12(b) Security American Depositary Shares, each representing 2 Ordinary Shares, no par value
Trading Symbol CANF
Security Exchange Name NYSE
Entity Common Stock, Shares Outstanding 2,618,425
Business Contact  
Document Information [Line Items]  
Entity Address, Address Line One 26 Ben Gurion Street
Entity Address, City or Town Ramat Gan
Entity Address, Postal Zip Code 5257346
Entity Address, Country IL
City Area Code +972
Local Phone Number (3) 924-1114
Contact Personnel Name Motti Farbstein
Contact Personnel Fax Number +972 (3) 924-9378
Contact Personnel Email Address motti@canfite.co.il